Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

<p>Abstract</p> <p>Background</p> <p>Cellular therapy after organ transplantation is emerging as an intriguing strategy to achieve dose reduction of classical immunosuppressive pharmacotherapy. Here, we introduce a new scoring system to assess treatment-emergent adverse...

Full description

Bibliographic Details
Main Authors: Dillmann Johannes, Popp Felix C, Fillenberg Barbara, Zeman Florian, Eggenhofer Elke, Farkas Stefan, Scherer Marcus N, Koller Michael, Geissler Edward K, Deans Robert, Ladenheim Deborah, Loss Martin, Schlitt Hans J, Dahlke Marc H
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Trials
Subjects:
Adherent adult stem cells
Mesenchymal stem cells
Multipotent adult progenitor cells
Solid organ transplantation
Immunotherapy
Scoring adverse events
Phase I trial
Online Access:http://www.trialsjournal.com/content/13/1/211

Internet

http://www.trialsjournal.com/content/13/1/211

Similar Items